SPH Phililab an innovation pharmaceutical company that develop, registrar, and manufacture generic and modified new drug product in USA and China. Our product portfolio focus on the two largest pharmaceutical markets in the world, plus our unique background of management team and scientists made us a pioneer as an international player in the pharmaceutical industry. We also provide services to small and large healthcare companies includes a full spectrum of contract R&D needs of pharmaceutical products. Our 12,000 square-foot state-of-art development laboratories are located in Plymouth Meeting, PA, USA. They contain the following functional units: GMP Analytical Quality Service Laboratories: for product release and method validation. The labs are equipped with top brand analytical instruments that are capable of the full spectrum of pharmaceutical analysis to support API and product releases, method validations, and in-vitro BE studies. A separate R&D analytical method development lab is also on site. Formulation Suites: for animal and phase I&II clinical supply. The suites are equipped with high quality formulation equipment that can manufacture oral solids, injections, suspensions, ointments and creams, oral films, and inhalation products.